ArticleAmerican journal of translational research2025
Epidemiologic characteristics of immunoglobulin M antibodies in lower respiratory tract infection pathogens of children: association with severe pneumonia in Chengdu city from 2019 to 2023.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the epidemiologic characteristics of serum immunoglobulin M (IgM) antibody aming six pathogens in children with acute lower respiratory tract infections (LRTI) and its association with severe pneumonia, thereby providing a basis for clinical diagnosis and treatment.
methodsA total of 25,693 children with lower respiratory tract infections who were hospitalized in the Department of Respiratory Medicine at Chengdu Women's and Children's Central Hospital from 2019 to 2023 were included and retrospectively analyzed in the study. The epidemiologic characteristics of serum IgM antibodies for six LRTI pathogens in the enrolled children were analyzed. Logistic regression analysis was conducted to identify risk factors for severe pneumonia.
resultsThe IgM positive detection rate among the six pathogens was 30.26%. In addition, the IgM positive detention rates among Mycoplasma pneumoniae (MP), Parainfluenza virus (PVI) and Influenza B virus (IFV-B) of female children were higher than those of male children (P < 0.05); Children who were younger than 1 year oldshowed the lowest IgM positive detention rates of MP and IFV-B (P < 0.05). The positivity rates of IgM antibodies for MP, IFV-B, PIV, and Respiratory syncytial virus (RSV) markedly varied across different lower respiratory tract infections (P < 0.001; P = 0.007; P = 0.004; P < 0.001). The IgM positive detection rate of two or more pathogens before COVID-19 pandemic were higher in comparison to those post COVID-19 (P < 0.05). Compared to the non-severe group, children with severe pneumonia showed a relatively lower detection rate of MP but a significantly higher detection rate of RSV. The results of multiple logistic regression analysis suggested that age and gender were independent influencing factors for severe pneumonia, with an area under the Receiver Operating Characteristics curve of 0.727.
conclusionIn Chengdu city, the positivity rates of IgM antibodies for LRTI pathogens in children exhibited seasonal, age-related, and diagnostic category characteristics-related variations. Severe pneumonia cases were characterized by RSV infection and younger age. Clinicians should take epidemiologic features into consideration to optimize their diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.